SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Sections 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 27, 2002
--------------
FRESENIUS MEDICAL CARE HOLDINGS, INC.
--------------------------------------
(Exact name of registrant as specified in its charter)
New York
-------------------------------------------------
(State or other jurisdiction of incorporation)
1-3720 13-3461988
- ----------------------- --------------------------------
(Commission File Number (IRS Employer Identification No.)
95 Hayden Avenue Lexington, Massachusetts 02420
-------------------------------------------------------
(Address or principal executive offices) (Zip Code)
Registrant's telephone number, including area codes: (781) 402-9000
--------------
Not Applicable
------------------------------------------------------------
(Former name or former address, if changed since last report)
ITEM 5. Other Events
On March 27, 2002, Fresenius Medical Care AG, the parent corporation of
Fresenius Medical Care Holdings, Inc., announced that, based on its
calculation of its cumulative adjusted cash flow for the five years
ended December 31, 2001, no special dividend would be payable on the
Class D Special Dividend Preferred Stock of Fresenius Medical Care
Holdings, Inc. Copies of Fresenius Medical Care AG's announcement, and
of the computations and certificates referred to in that announcement,
are annexed as exhibits to this Report.
ITEM 7. Financial Statements and Exhibits
Exhibit 99.1 Investor News release dated March 27, 2002
Exhibit 99.2 Chief Financial Officer's Certificate with respect
to the calculation of Fresenius Medical Care AG's
Cumulative Adjusted Cash Flow for the five years ended
December 31, 2001.
Exhibit 99.3 Opinion of KMPG Deutsche Treuhand-Gesellschaft
Aktiengesellschaft Wirtschaftsprufungsgesellschaft
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
FRESENIUS MEDICAL CARE
HOLDINGS, INC.
/s/ BEN J. LIPPS
--------------------------------------
DATE: March 27, 2002 Name: Ben J. Lipps
Title: Chief Executive Officer
2